VanEck Associates
CRSP icon

VanEck Associates’s CRISPR Therapeutics CRSP Stock Holding History

VanEck Associates’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$4.06M Sell
85,294
-537
-0.6% -$28.3K ﹤0.01% 866
2025
Q4 		$4.5M Buy
85,831
+2,187
+3% +$131K ﹤0.01% 820
2025
Q3 		$5.42M Buy
83,644
+634
+0.8% +$36.4K 0.01% 736
2025
Q2 		$4.04M Hold
83,010
– – ﹤0.01% 800
2025
Q1 		$2.83M Hold
83,010
– – ﹤0.01% 899
2024
Q4 		$3.27M Buy
83,010
+81,464
+5,269% +$3.85M ﹤0.01% 839
2024
Q3 		$71K Sell
1,546
-78,228
-98% -$3.97M ﹤0.01% 1266
2024
Q2 		$4.31M Buy
79,774
+7,830
+11% +$453K 0.01% 631
2024
Q1 		$4.9M Buy
71,944
+4,103
+6% +$294K 0.01% 588
2023
Q4 		$4.25M Sell
67,841
-4,989
-7% -$276K 0.01% 587
2023
Q3 		$3.31M Sell
72,830
-3,933
-5% -$203K 0.01% 612
2023
Q2 		$4.31M Sell
76,763
-5,863
-7% -$333K 0.01% 545
2023
Q1 		$3.74M Sell
82,626
-10,715
-11% -$520K 0.01% 550
2022
Q4 		$3.79M Buy
93,341
+14,084
+18% +$747K 0.01% 533
2022
Q3 		$5.18M Sell
79,257
-47,002
-37% -$3.41M 0.02% 430
2022
Q2 		$7.67M Buy
126,259
+12,198
+11% +$717K 0.02% 374
2022
Q1 		$7.16M Buy
114,061
+10,015
+10% +$629K 0.01% 431
2021
Q4 		$7.88M Buy
104,046
+7,694
+8% +$672K 0.02% 418
2021
Q3 		$10.8M Sell
96,352
-7,807
-7% -$980K 0.03% 337
2021
Q2 		$16.9M Sell
104,159
-14,922
-13% -$1.81M 0.04% 272
2021
Q1 		$14.5M Buy
+119,081
New +$18M 0.04% 278

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
OAG
Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
GP
GSK plc London $599M AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
SOCM
SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return